Trial Profile
Effects of alendronic acid on bone strength, soft tissue mass and bone turnover markers in treatment-naive postmenopausal Japanese women with osteoporosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2013
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics; Therapeutic Use
- 28 Nov 2013 New trial record
- 08 Oct 2013 Results presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.